英文摘要 |
Influenza virus is one of the most common viruses infecting human beings. Although it often causes acute and mild respiratory symptoms, it sometimes can induce severe lung injury. For instance, 1918 Spanish flu and high pathogenic avian influenza virus (H5N1) are two examples that influenza infection can cause severe morbidity and even death. Vaccination is the best strategy for prevention of influenza virus infection. Current inactivated vaccine can induce robust neutralizing antibody against specific influenza strains. However, because of its mutation-prone nature, influenza virus can easily escape from antibody attack. This review introduces the immune responses stimulated by infection of influenza virus, including innate and adaptive immunity, and how host immunity can eradicate virus. We also discuss the immunopathology caused by over-reactive immune responses. The innate immunity is the first-line host defense against influenza infection, including certain inflammatory cells, like macrophages and dendritic cells, cytokines and cellular receptors that recognize specific molecular signatures of pathogens. Influenza virus can trigger three classes of innate receptors, the Toll-like receptor(TLR), RIG-I-like receptor(RLR) and Nod-like receptor(NLR) that result in production of proinflammatory cytokines and activation of innate immune responses. Among the induced cytokines, type I interferon is the most important. The innate immunity not only controls early viral replication, but also determines the quality and strength of the adaptive immunity. The adaptive immunity against influenza infection includes B cell-secreted neutralizing antibodies and T cell immunity, particularly, CD8 T cell immunity which is responsible for viral clearance. T cells recognize the epitopes of conserved viral internal proteins, hence exhibit the potential for inducton of immune responses against different strains or subtypes of influenza virus. Understanding the immune responses and immunopathology caused by influenza infection can help develop ideal vaccine that can stimulate robust immune responses but avoid causing host damage in order to cope with the potential threat of future influenza pandemics. |